Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply by Authors.
Harmatz IM, Alkhatib KY, Leff M, Nolazco JI, Michel KF, Slinger M, McLauchlan N, Cortese BD, Roberson DS, Schurhamer B, Lee DJ, Malkowicz SB, Trinh QD, Bivalacqua TJ, Guzzo TJ, Pierorazio PM. Harmatz IM, et al. Among authors: bivalacqua tj. Urol Pract. 2024 May;11(3):558. doi: 10.1097/UPJ.0000000000000568. Epub 2024 May 1. Urol Pract. 2024. PMID: 38560940 No abstract available.
Prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey.
Harmatz IM, Alkhatib KY, Leff M, Nolazco JI, Michel KF, Slinger M, McLauchlan N, Cortese BD, Roberson DS, Schurhamer B, Lee DJ, Malkowicz SB, Trinh QD, Bivalacqua TJ, Guzzo TJ, Pierorazio PM. Harmatz IM, et al. Among authors: bivalacqua tj. Urol Pract. 2024 May;11(3):547-556. doi: 10.1097/UPJ.0000000000000553. Epub 2024 Apr 2. Urol Pract. 2024. PMID: 38564816
Reply by Authors.
Kohn TP, DuComb W, Sury K, Choi U, Bivalacqua TJ. Kohn TP, et al. Among authors: bivalacqua tj. Urol Pract. 2024 May;11(3):516. doi: 10.1097/UPJ.0000000000000551. Epub 2024 Apr 2. Urol Pract. 2024. PMID: 38564802 No abstract available.
Reply by Authors.
Patel SH, Gabrielson AT, Chan S, Schwartz D, Collins C, Singla N, Trock B, Bivalacqua TJ, Hahn N, Kates MR. Patel SH, et al. Among authors: bivalacqua tj. J Urol. 2024 May 7:101097JU0000000000004017. doi: 10.1097/JU.0000000000004017. Online ahead of print. J Urol. 2024. PMID: 38713596 No abstract available.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients with BCG-Unresponsive Non-muscle Invasive Bladder Cancer: 5 Year Follow-Up from a Phase 3 Trial.
Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J Jr, Lane BR, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Narayan VM, et al. Among authors: bivalacqua tj. J Urol. 2024 May 5:101097JU0000000000004020. doi: 10.1097/JU.0000000000004020. Online ahead of print. J Urol. 2024. PMID: 38704840
Pathologic and survival outcomes following radical cystectomy for "progressive" and "de novo" muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.
Xia L, Dadabhoy A, Wood EL, Mehta SV, Roberson DS, Guzzo TJ, Bivalacqua TJ, Daneshmand S. Xia L, et al. Among authors: bivalacqua tj. Urol Oncol. 2024 May 1:S1078-1439(24)00438-1. doi: 10.1016/j.urolonc.2024.04.020. Online ahead of print. Urol Oncol. 2024. PMID: 38697874
Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma.
Singla N, Nirschl TR, Obradovic AZ, Shenderov E, Lombardo K, Liu X, Pons A, Zarif JC, Rowe SP, Trock BJ, Hammers HJ, Bivalacqua TJ, Pierorazio PM, Deutsch JS, Lotan TL, Taube JM, Ged YMA, Gorin MA, Allaf ME, Drake CG. Singla N, et al. Among authors: bivalacqua tj. Sci Rep. 2024 Jan 17;14(1):1458. doi: 10.1038/s41598-024-51889-9. Sci Rep. 2024. PMID: 38228729 Free PMC article.
453 results